Syntax Research’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.3K Sell
190
-221
-54% -$51.5K 0.04% 94
2026
Q1
$100K Hold
411
0.06% 78
2025
Q4
$85.1K Hold
411
0.05% 84
2025
Q3
$76.2K Hold
411
0.05% 83
2025
Q2
$62.8K Hold
411
0.04% 81
2025
Q1
$68.2K Hold
411
0.05% 85
2024
Q4
$59.4K Hold
411
0.04% 84
2024
Q3
$66.6K Hold
411
0.05% 83
2024
Q2
$60.1K Hold
411
0.05% 77
2024
Q1
$65K Hold
411
0.05% 79
2023
Q4
$64.4K Hold
411
0.05% 77
2023
Q3
$64K Buy
+411
New +$67.8K 0.05% 81

Other funds holding JNJ

Syntax Research's JNJ Position: Q2 2026 in Review

Syntax Research reduced its Johnson & Johnson (JNJ) stake by 54% in Q2 2026, selling an estimated $51.5K and leaving 190 shares worth $48.3K. The position accounts for 0.04% of the portfolio, ranked #94.

Syntax Research first reported a position in JNJ in Q3 2023 and has held it in 12 quarters since. The position peaked at $100K in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Syntax Research held 190 shares of Johnson & Johnson worth $48.3K as of Q2 2026.
  • Syntax Research sold 221 Johnson & Johnson shares in Q2 2026, an estimated $51.5K.
  • Johnson & Johnson made up 0.04% of Syntax Research's portfolio in Q2 2026, its #94 holding.
  • Syntax Research first reported a position in Johnson & Johnson in Q3 2023 and has held it in 12 quarters since.
  • Syntax Research's Johnson & Johnson position peaked at $100K in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.